Skip to content

Clinical trials

Terminated Phase 1/2 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Status: Terminated Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20096
20101
20111
20131
20141
20151
20162
20174
20183
20194
20201
20212
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Taiwan Liposome Company2
AVEO Pharmaceuticals, Inc.1
Abramson Cancer Center at Penn Medicine1
Adherex Technologies, Inc.1
Apollomics (Australia) Pty. Ltd.1
Bristol-Myers Squibb1
Cellestia Biotech AG1
CureTech Ltd1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Edward Kim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular35
Liver Neoplasms5
Carcinoma, Renal Cell4
Neoplasm Metastasis4
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Triple Negative Breast Neoplasms3
Uterine Cervical Neoplasms3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.